Successful Management of Severe Bromethalin Toxicosis in a Dog

Bridget M. Lyons, Robert H. Poppenga, Vincent J. Thawley, Lori S. Waddell

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


ABSTRACTThe use of bromethalin rodenticides has risen since 2011, and in some states, it is the most common rodenticide ingestion reported to poison control. Although intravenous lipid emulsion (ILE) has been previously reported to lower serum desmethylbromethalin levels in an asymptomatic dog, and repeated mannitol has been investigated in a laboratory setting, there are no published reports of successful treatment of symptomatic bromethalin toxicosis in dogs. A 9 yr old castrated male Norwich terrier was evaluated for obtunded mentation, seizures, cranial nerve deficits, and tetraparesis secondary to bromethalin toxicosis. The patient was treated with ILE, mannitol, and ginkgo biloba and returned to normal neurological function. Bromethalin exposure was confirmed by serum desmethylbromethalin levels. Previous literature indicates that the prognosis for patients who suffer from symptomatic bromethalin toxicosis is poor to grave, and the return to normal neurological function after severe toxicosis has not been reported. ILE, mannitol, and ginkgo biloba are readily available and relatively inexpensive, and in combination may be of benefit in symptomatic bromethalin intoxication.

Original languageEnglish (US)
Pages (from-to)e55502
JournalJournal of the American Animal Hospital Association
Issue number5
StatePublished - Sep 1 2019
Externally publishedYes

ASJC Scopus subject areas

  • Small Animals


Dive into the research topics of 'Successful Management of Severe Bromethalin Toxicosis in a Dog'. Together they form a unique fingerprint.

Cite this